ATS's New CEO Bets on a Fixed-Cost Transformation to Reach 15% Margins
A portfolio review uncovers opportunity across radiopharma, nuclear, and aftermarket services.
ATS · Earnings Call · 2026-08-06
A New Playbook for Margin Expansion
When Doug Wright took the helm at ATS Corporation, the mandate was clear: find the path to higher margins. Today, after a comprehensive portfolio review and site assessments, he has unveiled the blueprint. The company is launching an 18-month fixed cost transformation program, targeting roughly half of the improvement needed to reach its 15% operating margin target. The other half will come from growth in higher-margin aftermarket services, better commercial discipline, and innovation.
We've initiated an 18-month program to simplify our operations, improve efficiency and strengthen the foundation for long-term profitable growth and shareholder returns.
The program starts with a focus on Europe, where the review identified excess capacity. Initial savings are estimated at $20 million, which is about 30% of the total opportunity. This fixed costs reduction is expected to be a structural change, not just a one-time cost cut. Anne Cybulski, Interim CFO, emphasized: “Taken together, these actions will change our cost structure, not just our cost this year.” — Michael Anne Cybulski, Interim Chief Financial Officer · 2026-08-06
This is a notable pivot from prior quarters, where the company had been managing the decline in transportation and a slower bookings environment. In February 2026, Doug had already signaled the importance of margin expansion: “we will deploy capital with a high level of discipline as usual, but with an emphasis on improving our margins, our aftermarket mix and bringing in new technologies.” — Douglas Wright, Chief Executive Officer · 2026-02-04 Now he's putting that philosophy into action.
Where the Growth Will Come From
The portfolio review reinforced confidence in the underlying markets, particularly life sciences and energy. Doug highlighted radiopharma as the "fastest-growing part of our life science business." The company's backlog in radiopharma is now twice as large as its GLP-1 backlog, reflecting a shift in demand. “So I would say, first of all, it is the fastest-growing part of our life science business.” — Douglas Wright, Chief Executive Officer · 2026-08-06 The science behind this is exciting, with complex manufacturing environments that require ATS's containment and automation expertise.
Nuclear is another area of focus. Doug noted, "within nuclear, ATS has a strong track record supporting CANDU reactor refurbishment and life extension programs." The company is now engaging in early-stage work on small modular reactors and next-generation large reactors. On a single reactor build, ATS's portion could represent $50 million to $150 million in revenue. This is a long-term growth engine, but one that the company is positioning for.
The return on investment framework is central to this strategy. The company is applying a disciplined cash return on investment model to internally assess every division and facility. This framework also guides M&A, where the appetite remains unchanged, but the bar is higher.
What This Means for Investors
The market reaction may be muted, but the strategic shift is significant. ATS is fundamentally reshaping its cost structure while simultaneously investing in the fastest-growing segments. The 15% operating margin target is not just a financial goal; it's a cultural change. As Doug put it, “My conviction in ATS is stronger today than when I joined the company.” — Douglas Wright, Chief Executive Officer · 2026-08-06
The company's backlog of ~$1.9 billion provides near-term visibility, with more than 80% coming from life sciences, food and beverage, and energy. The margin target is now supported by a concrete plan: half from fixed cost transformation, half from mix and commercial actions.
In prior quarters, management had been cautious about giving specifics on margin progression. Anne Cybulski had noted in May: “they're really independent swim lanes for us.” — Douglas Wright, Chief Executive Officer · 2026-05-28 Now that plan has been quantified.
The second quarter revenue guidance of $660 million to $700 million suggests a modest decline, but the company expects margins to strengthen in the second half as backlog converts and cost actions take hold. The transformation program is expected to take 18 months to implement, with full benefits accruing over the following year.
ATS is becoming a more focused, higher-margin business. The transformation program is the vehicle to unlock that potential. While there is inherent lumpiness in its large project business, the direction is clear. This is a company that is willing to make tough decisions to improve long-term shareholder value.